Recent Media Coverage

View All
2019-10-25 research healey-center-for-als;neurology
Pharma TimesOctober | 25 | 2019

First patient enrolled in Oxford BioDynamics’ ALS biomarker study

Pharma Times writes about Oxford BioDynamics' role in testing a new ALS drug, with primary investigator James Berry, MD, MPH of Mass General.

2019-09-20 research neurology;healey-center-for-als
Boston GlobeSeptember | 20 | 2019

Mass General to begin ALS trials that test several drugs at once

Boston Globe coverage of the HEALEY ALS Platform Trial, which is starting with five promising new drugs and ambitious plans to accelerate the pace of discovery for ALS treatments.